Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.1.60ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.49EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.49EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.49ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.49ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.49EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.49EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.49ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.1.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.1.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.1.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.1.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KP.1.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KP.1.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.4.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.4.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.4.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.4.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDD.1.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XDD.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDD.1.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XDD.1.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XDD.1.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XDD.1.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XDD.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDD.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDNEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-1649.2South Korea
XDNEWon-ECACACAATCGATGCGCAGTA20502636526346R-2361.24South Korea
XDNECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-2824.15Germany
XDNECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
XDNEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
XDNEHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
XDNENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
XDNENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LT.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LT.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LT.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LT.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LT.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LT.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LT.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.8.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.8.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used